MedPath

Impact of New Anthropometric Indices on Outcomes After Cardiac Surgery

Conditions
Coronary Artery Disease
Anthropometry
Cardiometabolic Risk Factors
Cardiac Anesthesia
Cardiac Surgery
Registration Number
NCT05403294
Lead Sponsor
TC Erciyes University
Brief Summary

Obesity is associated with a number of risk factors for cardiovascular disease. Body mass index (BMI) is the most commonly recommended and used anthropometric measure to classify general obesity in clinical and epidemiological studies. It is widely accepted that obesity increases the risk of heart disease and is thought to be a risk factor for adverse outcomes after cardiac surgery. However, recent studies show paradoxical results, wherein obese patients can experience fewer adverse events and lower mortality than patients with normal-low body mass index(BMI) . The discriminative capacity of BMI has been criticized because it cannot distinguish muscle mass from fat mass, or reflect fat distribution . Alternatively, abdominal obesity indices, such as waist circumference (WC) and waist-to-height ratio (WHtR), have been suggested to be better predictor of cardiometabolic abnormalities because they modulate the limitation of BMI. However, they were insufficient in studies.For this reason, scientists turned to find a new anthropometric formula that could better detect obesity-related mortality and morbidity and they developed 2 new methods. Body Shape İndex (ABSI) is calculated using waist circumference, BMI and height parameters. Body Roundness İndex (BRI) is calculated using waist circumference and height parameters. These new indices may reflect visceral adiposity and strongly predict cardiovascular risk, postsurgical outcomes and resource utilisation.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
240
Inclusion Criteria
  • open heart surgery
  • voluntary patients
Exclusion Criteria
  • emergency surgery
  • off-pump or robotic surgery
  • surgery requiring deep hypothermic circulatory arrest
  • reluctant patients

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
permanent rhythm device insertionwithin 30 days of the procedure

Number of Patients requiring insertion of a permanent device

cardiac arrestwithin 30 days of the procedure

number of patients with cardiac arrest

mortalitywithin 30 days of the procedure

Number of death at 30 days after surgery

postoperative strokewithin 30 days of the procedure

Number of patients with postoperative stroke

new atrial fibrillation/flutterwithin 30 days of the procedure

Number of Partients with new atrial fibrillation/flutter

Secondary Outcome Measures
NameTimeMethod
intensive care unit (ICU) readmissionswithin 30 days of the procedure

number of patients with intensive care unit readmission

prolonged ventilationwithin 30 days of the procedure

number of patients experiencing prolonged postoperative pulmonary ventilation (\>24 hours)

sepsis /deep sternal infectionwithin 30 days of the procedure

number of patients with sepsis, deep sternal wound infection or mediastinitis

total intensive care unit (ICU) hourswithin 30 days of the procedure

total intensive care unit (ICU) hours

pulmonary complicationswithin 30 days of the procedure

number of patients with pneumonia or pleural effusion

renal failure / renal dialysiswithin 30 days of the procedure

number of patient with acute renal failure or worsening renal function result

© Copyright 2025. All Rights Reserved by MedPath